DBV TECHNOLOGIES (EPA:DBV) | Finanzwire

Basculer en Français

10810	Companies
234097	Keywords
162861	Articles
125113	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 03/28/2025 at 03:30, 1 year 4 months ago

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
DBV Technologies secures financing of up to $306.9 million (€284.5 million) to advance Viaskin Peanut Patch through FDA submission and US commercial launch. Investors include MPM BioImpact, Adage Capital Management, Janus Henderson Investors, and more

Financing Commercial Launch DBV Technologies FDA Submission Viaskin Peanut Patch
BRIEF

published on 03/24/2025 at 07:35, 1 year 4 months ago

DBV Technologies Anticipates Regulatory Progress with the FDA

FDA Agreement DBV Technologies Viaskin Peanut Treasury 2024 SPEED Study
PRESS RELEASE

published on 03/24/2025 at 07:30, 1 year 4 months ago

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
DBV Technologies secures FDA agreement for Viaskin Peanut Patch BLA submission in 4-7-year-olds, accelerating launch timeline by approximately one year. Unaudited 2024 financial results reported

FDA Agreement DBV Technologies Unaudited Financial Results Viaskin Peanut Patch BLA Submission
BRIEF

published on 02/25/2025 at 22:06, 1 year 5 months ago

DBV Technologies at AAAAI/WAO Congress to Present Advances in Peanut Allergy

Clinical Study DBV Technologies Peanut Allergy AAAAI/WAO Congress VIASKIN® Patch
PRESS RELEASE

published on 02/25/2025 at 22:01, 1 year 5 months ago

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates

DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
BRIEF

published on 01/13/2025 at 22:10, 1 year 6 months ago

DBV Technologies Half-Yearly Liquidity Statement

Liquidity Contract ODDO BHF Stock Market Transactions DBV Technologies VIASKIN®
PRESS RELEASE

published on 01/13/2025 at 22:05, 1 year 6 months ago

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
DBV Technologies issues Half-Year Report on liquidity contract with ODDO BHF, revealing assets in the account and transaction details

Liquidity Contract Half-year Report Biopharmaceutical Company ODDO BHF DBV Technologies
BRIEF

published on 12/02/2024 at 22:35, 1 year 8 months ago

DBV Technologies: Voting rights and shares as of November 30, 2024

Share Capital Voting Rights Actions DBV Technologies NYSE Euronext Paris
PRESS RELEASE

published on 12/02/2024 at 22:30, 1 year 8 months ago

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
Company provides update on total voting rights and shares as of November 30, 2024 in compliance with AMF regulations

Shares Total Voting Rights AMF Regulations NYSE Euronext Paris November 30 2024
BRIEF

published on 11/20/2024 at 15:33, 1 year 8 months ago

Braidwell LP Crosses Thresholds at DBV Technologies

Actions Investment Crossing Thresholds DBV Technologies Braidwell LP

Accesswire

Published on 08/07/2026 at 00:45, 2 hours 55 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 4 hours 25 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 5 hours 25 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada
Published on 08/06/2026 at 22:05, 5 hours 35 minutes ago

Innodata Reports Record Second Quarter 2026 Results
Published on 08/06/2026 at 22:00, 5 hours 40 minutes ago

Gold Terra Announces Closing of Second Tranche of the C$10.8M LIFE

View all ACCESSWIRE

EQS Group

Published on 08/06/2026 at 22:50, 4 hours 50 minutes ago

Amrize Reports Second Quarter 2026 Results
Published on 08/06/2026 at 22:15, 5 hours 25 minutes ago

BIRKENSTOCK SEEKS TO FILL VACANCY IN THE BOARD OF DIRECTORS WITH AN INDEPENDENT DIRECTOR, FOLLOWING ALEXANDRE ARNAULT'S RESIGNATION DUE TO PROFESSIONAL COMMITTMENTS
Published on 08/06/2026 at 21:45, 5 hours 55 minutes ago

FP Markets Analysis: Japanese Yen at a Crossroads as Markets Weigh Next Move
Published on 08/06/2026 at 19:05, 8 hours 35 minutes ago

Cision Wins 2026 MarTech Breakthrough Awards for Social Listening, Press Release Distribution, and AEO
Published on 08/06/2026 at 18:24, 9 hours 15 minutes ago

EQS-Adhoc: Allgeier SE: Allgeier Increases Revenue by 10 Percent in the First Half of 2026 and Confirms Its Guidance for 2026

Les Echos

Published on 08/06/2026 at 18:26, 9 hours 14 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 17:45, 9 hours 55 minutes ago

Declaration of voting rights at the end of July 2026
Published on 08/06/2026 at 17:45, 9 hours 55 minutes ago

July 2026
Published on 08/06/2026 at 17:35, 10 hours 5 minutes ago

Groupe des Assurances du Crédit Mutuel (GACM)’s Solvency II ratio was 227% as of June 30, 2026
Published on 08/06/2026 at 17:35, 10 hours 5 minutes ago

Availability of the financial statements of Groupe des Assurances du Crédit Mutuel for the first half of 2026

View all LES ECHOS COMFI WIRE